Nanoparticles of alkylglyceryl-dextran-graft-poly(lactic acid) for drug delivery to the brain: Preparation and in vitro investigation

Acta Biomaterialia

Volumn 23, Issue , 2015, Pages 250-262

  Toman, Petr ^a   Lien, Chun Fu ^a   Ahmad, Zeeshan ^b   Dietrich, Susanne ^a   Smith, James R ^a   An, Qian ^a   Molnár, Éva ^a   Pilkington, Geoffrey J ^a   Górecki, Darek C ^a   Tsibouklis, John ^a   Barbu, Eugen ^a  

^a UNIVERSITY OF PORTSMOUTH   (United Kingdom)

^b DE MONTFORT UNIVERSITY   (United Kingdom)

Author keywords

Alkylglycerols; Butylglyceryldextran; Drug delivery; Nanoparticles; Poly(lactic acid)

Indexed keywords

ATOMIC FORCE MICROSCOPY; BLOOD; CONTROLLED DRUG DELIVERY; DEXTRAN; ENDOTHELIAL CELLS; FLUORESCENCE; GRAFTING (CHEMICAL); LACTIC ACID; LIGHT SCATTERING; SCANNING ELECTRON MICROSCOPY; TARGETED DRUG DELIVERY; TOXICITY;

ALKYLGLYCEROL; BUTYLGLYCERYLDEXTRAN; COLLOIDAL SYSTEM; FLUORESCENT MARKERS; IMMUNOGENIC PROPERTIES; IN-VITRO; NANO PARTICULATES; POLY LACTIC ACID; POLY(LACTIC ACID); STABILIZING PROPERTIES;

NANOPARTICLES;

CYANAMIDE; DEXTRAN DERIVATIVE; DOXORUBICIN; FLUORESCEIN ISOTHIOCYANATE; GLYCEROL DERIVATIVE; NANOCARRIER; POLYLACTIC ACID; RHODAMINE B; SOLVENT; DEXTRAN; LACTIC ACID; NANOCAPSULE; POLYMER;

ANIMAL CELL; ARTICLE; ATOMIC FORCE MICROSCOPY; BLOOD BRAIN BARRIER; BRAIN CAPILLARY ENDOTHELIAL CELL; CONFOCAL MICROSCOPY; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; ELECTROSPRAY; HUMAN; HUMAN CELL; HYDRODYNAMICS; IN VITRO STUDY; LIGHT SCATTERING; MOUSE; MTT ASSAY; NANOPHARMACEUTICS; NONHUMAN; PARTICLE SIZE; PH; PRIORITY JOURNAL; SCANNING ELECTRON MICROSCOPY; ZETA POTENTIAL; ANIMAL; CELL LINE; CHEMISTRY; DIFFUSION; DRUG FORMULATION; ENDOTHELIUM CELL; PROCEDURES; ULTRASTRUCTURE;

SPONDIAS PURPUREA;

ANIMALS; BLOOD-BRAIN BARRIER; CELL LINE; DEXTRANS; DIFFUSION; DRUG COMPOUNDING; ENDOTHELIAL CELLS; LACTIC ACID; MICE; NANOCAPSULES; PARTICLE SIZE; POLYMERS;

EID: 84938200180     PISSN: 17427061     EISSN: 18787568     Source Type: Journal    
DOI: 10.1016/j.actbio.2015.05.009     Document Type: Article

References (46)

1. J. Olesen, A. Gustavsson, M. Svensson, H.U. Wittchen, B. Jönsson CDBE2010 study group; European Brain Council The economic cost of brain disorders in Europe Eur. J. Neurol. 19 2012 155 162
2. W.M. Pardridge Drug targeting to the brain Pharm. Res. 24 2007 1733 1744
3. Y. Omidi, and J. Barar Impacts of blood-brain barrier in drug delivery and targeting of brain tumors BioImpacts 2 2012 5 22
4. J. Kreuter Nanoparticulate systems for brain delivery of drugs Adv. Drug Deliv. Rev. 64 2012 213 222
5. S. Wohlfart, A.S. Khalansky, S. Gelperina, D. Begley, and J. Kreuter Kinetics of transport of doxorubicin bound to nanoparticles across the blood-brain barrier J. Control. Release 154 2011 103 107
6. A. Trapani, E. De Giglio, D. Cafagna, N. Denora, G. Agrimi, T. Cassano, and et al. Characterization and evaluation of chitosan nanoparticles for dopamine brain delivery Int. J. Pharm. 419 2011 296 307
7. R.T. Frank, K.S. Aboody, and J. Najbauer Strategies for enhancing antibody delivery to the brain Biochim. Biophys. Acta 1816 2011 191 198
8. E. Barbu, E. Molnàr, J. Tsibouklis, and D.C. Górecki The potential for nanoparticle-based drug delivery to the brain: overcoming the blood-brain barrier Expert Opin. Drug Deliv. 6 2009 553 565
9. J. Kreuter, and S. Gelperina Use of nanoparticles for cerebral cancer Tumori 94 2008 271 277
10. R. Alyautdin, I. Khalin, M.I. Nafeeza, M.H. Haron, and D. Kuznetsov Nanoscale drug delivery systems and the blood-brain barrier Int. J. Nanomed. 9 1 2014 795 811
11. J. Nicolas, S. Mura, D. Brambilla, N. MacKiewicz, and P. Couvreur Design, functionalization strategies and biomedical applications of targeted biodegradable/biocompatible polymer-based nanocarriers for drug delivery Chem. Soc. Rev. 42 3 2013 1147 1235
12. M. Charles-Harris, S. del Valle, E. Hentges, P. Bleuet, D. Lacroix, and J.A. Planell Mechanical and structural characterisation of completely degradable polylactic acid/calcium phosphate glass scaffolds Biomaterials 28 2007 4429 4438
13. M.S. Romero-Cano, and B. Vincent Controlled release of 4-nitroanisole from poly(lactic acid) nanoparticles J. Control. Release 82 2002 127 135
14. T. Verrecchia, G. Spelnehauer, D.V. Basile, A. Murry-Brelier, Y. Archimbaud, and M. Veillard Non-stealth (poly(lactic acid/albumin)) and stealth (poly(lactic acid-polyethylene glycol)) nanoparticles as injectable drug carriers J. Control. Release 36 1995 49 61
15. J.A. Cadée, M.J. van Luyn, L.A. Brouwer, J.A. Plantinga, P.B. van Wachem, C.J. de Groot, and et al. In vivo biocompatibility of dextran-based hydrogels J. Biomed. Mater. Res. 50 2000 397 404
16. K. Nagahama, Y. Mori, Y. Ohya, and T. Ouchi Biodegradable nanogel formation of polylactide-grafted dextran copolymer in dilute aqueous solution and enhancement of its stability by stereocomplexation Biomacromolecules 8 2007 2135 2141
17. Z. Zhao, Z. Zhang, L. Chen, Y. Cao, C. He, and X. Chen Biodegradable stereocomplex micelles based on dextran-block-polylactide as efficient drug deliveries Langmuir 29 2013 13072 13080
18. R. McCahon, and J. Hardman Pharmacology of plasma expanders Anaesth. Intensive Care Med. 8 2007 79 81
19. S.L. Easo, and P.V. Mohanan Dextran stabilized iron oxide nanoparticles: synthesis, characterization and in vitro studies Carbohydr. Polym. 92 1 2013 726 732
20. N. Jaulin, M. Appel, C. Passirani, G. Barratt, and D. Labarre Reduction of the uptake by a macrophagic cell line of nanoparticles bearing heparin or dextran covalently bound to poly(methyl methacrylate) J. Drug Target. 8 3 2000 165 172
21. K. Marigny, F. Pedrono, C.A. Martin-Chouly, H. Youmine, B. Saiag, and A.B. Legrand Modulation of endothelial permeability by 1-O-alkylglycerols Acta Physiol. Scand. 176 2002 263 268
22. B. Erdlenbruch, M. Alipour, G. Fricker, D.S. Miller, W. Kugler, H. Eibl, and et al. Alkylglycerol opening of the blood-brain barrier to small and large fluorescence markers in normal and C6 glioma-bearing rats and isolated rat brain capillaries Br. J. Pharmacol. 140 2003 1201 1210
23. P. Hülper, S. Veszelka, F.R. Walter, H. Wolburg, P. Fallier-Becker, J. Piontek, and et al. Acute effects of short-chain alkylglycerols on blood-brain barrier properties of cultured brain endothelial cells Br. J. Pharmacol. 169 2013 1561 1573
24. B. Erdlenbruch, C. Schinkhof, W. Kugler, D.E. Heinemann, J. Herms, H. Eibl, and et al. Intracarotid administration of short-chain alkylglycerols for increased delivery of methotrexate to the rat brain Br. J. Pharmacol. 139 2003 685 694
25. B. Erdlenbruch, V. Jendrossek, W. Kugler, H. Eibl, and M. Lakomek Increased delivery of erucylphosphocholine to C6 gliomas by chemical opening of the blood-brain barrier using intracarotidal pentylglycerols in rats Cancer Chemother. Pharmacol. 50 2002 299 304
26. B. Erdlenbruch, V. Jendrossek, H. Eibl, and M. Lakomek Transient and controllable opening of the blood-brain barrier to cytostatic and antibiotic agents by alkylglycerols in rats Exp. Brain Res. 135 2000 417 422
27. E. Molnár, E. Barbu, C.F. Lien, D.C. Górecki, and J. Tsibouklis Toward drug delivery into the brain: synthesis, characterization, and preliminary in vitro assessment of alkylglyceryl-functionalized chitosan nanoparticles Biomacromolecules 11 2010 2880 2889
28. P. Artursson Epithelial transport of drugs in cell culture. I: A model for studying the passive diffusion of drugs over intestinal absorptive (Caco-2) cells J. Pharm. Sci. 79 1990 476 482
29. S. Shu, X. Zhang, Z. Wu, Z. Wang, and C. Li Delivery of protein drugs using nanoparticles self-assembled from dextran sulphate and quaternized chitosan J. Control. Release 152 2011 170 172
30. M. Leonard, C. Fournier, and E. Dellacherie Comparative pore structure analysis of dextran-coated polystyrene particles J. Colloid Interface Sci. 220 1999 380 386
31. C. Houga, J.F. Le Meins, R. Borsali, D. Taton, and Y. Gnanou Synthesis of ATRP-induced dextran-b-polystyrene diblock copolymers and preliminary investigation of their self-assembly in water Chem. Commun. 29 2007 3063 3065
32. J.C. Ramirez, M. Sanchez-Chaves, and F. Arranz Functionalization of dextran with chloroacetate groups: immobilization of bioactive carboxylic acids Polymer 35 1994 2651 2655
33. A. Vollmer, K. Voiges, C. Bork, K. Fiege, K. Cuber, and P. Mischnick Comprehensive analysis of the substitution pattern in dextran ethers with respect to the reaction conditions Anal. Bioanal. Chem. 395 2009 1749 1768
34. M. Sanchez-Chaves, and F. Arranz Synthesis of amidoxime-containing modified dextran Polymer 37 1996 4403 4407
35. A.N. De Belder, Dextran, Amershaw Bioscience 2003, Report No: 18-1166-12.
36. K.C. Choi, J.Y. Bang, C. Kim, P.I. Kim, S.R. Lee, W.T. Chung, and et al. Antitumor effect of adriamycin-encapsulated nanoparticles of poly(DL-lactide-co-glycolide)-grafted dextran J. Pharm. Sci. 98 2009 2104 2112
37. S.A. Kulkarni, and S. Feng Effects of particle size and surface modification on cellular uptake and biodistribution of polymeric nanoparticles for drug delivery Pharm. Res. 30 10 2013 2512 2522
38. J. Qi, P. Yao, F. He, C. Yu, and C. Huang Nanoparticles with dextran/chitosan shell and BSA/chitosan core - Doxorubicin loading and delivery Int. J. Pharm. 393 2010 176 184
39. A.A. Clancy, Y. Gregoriou, K. Yaehne, and D.T. Cramb Measuring properties of nanoparticles in embryonic blood vessels: towards a physicochemical basis for nanotoxicity Chem. Phys. Lett. 488 2010 99 111
40. D. Le Broc-Ryckewaert, R. Carpentier, E. Lipka, S. Daher, C. Vaccher, D. Betbeder, and et al. Development of innovative paclitaxel-loaded small PLGA nanoparticles: Study of their antiproliferative activity and their molecular interactions on prostatic cancer cells Int. J. Pharm. 454 2 2013 712 719
41. C.F. Lien, E. Molnár, P. Toman, J. Tsibouklis, G.J. Pilkington, D.C. Górecki, and et al. In vitro assessment of alkylglyceryl-functionalized chitosan nanoparticles as permeating vectors for the blood-brain barrier Biomacromolecules 13 2012 1067 1073
42. M.N. Ragnaill, M. Brown, D. Ye, M. Bramini, S. Callanan, I. Lynch, and et al. Internal benchmarking of a human blood-brain barrier cell model for screening of nanoparticle uptake and transcytosis Eur. J. Pharm. Biopharm. 77 2011 360 367
43. A. Avdeef How well can in vitro brain microcapillary endothelial cell models predict rodent in vivo blood-brain barrier permeability? Eur. J. Pharm. Sci. 43 2011 109 124
44. M.A. Deli, C.S. Abrahám, Y. Kataoka, and M. Niwa Permeability studies on in vitro blood-brain barrier models: physiology, pathology, and pharmacology Cell. Mol. Neurobiol. 25 2005 59 127
45. J. Barar, and Y. Omidi Bioelectrical and permeability properties of brain microvasculature endothelial cells: effects of tight junction modulators J. Biol. Sci. 8 2008 556 562
46. C.P. Ordahl, B.A. Williams, and W. Denetclaw Determination and morphogenesis in myogenic progenitor cells: an experimental embryological approach Curr. Top. Dev. Biol. 48 2000 319 367